Skip to content
healthcare.dev
Get a free key

Arcalyst

NDC 73604-914, rilonacept, injection, powder, lyophilized, for solution, from Kiniksa Pharmaceuticals (UK), Ltd..

Product NDC
73604-914
Status
Listed
Labeler
Kiniksa Pharmaceuticals (UK), Ltd.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125249
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73604-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RILONACEPT160 mg/2mL
Package NDCNDC-11Package
73604-914-01736040914011 VIAL, SINGLE-USE in 1 CARTON (73604-914-01) / 2 mL in 1 VIAL, SINGLE-USE
73604-914-04736040914044 VIAL, SINGLE-USE in 1 CARTON (73604-914-04) / 2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ad965f38-dd22-4607-a673-2fb92f3b527a

Use it

Look up 73604-914 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73604-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73604-914. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.